HomeBIO • FRA
Biotest AG
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 124.20M | -42.29% |
Operating expense | 36.10M | -4.50% |
Net income | -21.40M | -172.54% |
Net profit margin | -17.23 | -225.67% |
Earnings per share | — | — |
EBITDA | -13.53M | -122.39% |
Effective tax rate | 28.90% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.80M | -50.65% |
Total assets | 1.42B | -2.09% |
Total liabilities | 906.90M | -1.31% |
Total equity | 509.60M | — |
Shares outstanding | 38.91M | — |
Price to book | 3.24 | — |
Return on assets | -3.86% | — |
Return on capital | -4.62% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.40M | -172.54% |
Cash from operations | -58.10M | -400.86% |
Cash from investing | -1.10M | 88.89% |
Cash from financing | -6.90M | -263.16% |
Net change in cash | -66.00M | -183.26% |
Free cash flow | -71.21M | -54.77% |
Previous close
€42.40
Day range
€42.20 - €42.20
Year range
€40.00 - €42.80
Market cap
1.45B EUR
Avg Volume
27.00
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
About
Founded
1946
Headquarters
Website
Employees
2,495
